Article Details

Delfi Diagnostics reels in $100M for blood-based cancer test

Retrieved on: 2021-01-14 23:03:45

Tags for this article:

Click the tags to see associated articles and topics

Delfi Diagnostics reels in $100M for blood-based cancer test. View article details on hiswai:

Excerpt

Existing investors Menlo Ventures, Samsara Biocapital, Illumina Ventures, Av8 Ventures also participated in the round, along with new investors ...

Article found on: www.bioworld.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up